Ann & Robert H. Lurie Children's Hospital of Chicago, formerly Children's Memorial Hospital and commonly known as Lurie Children's, is a nationally ranked pediatric acute care children's hospital located in Chicago, Illinois.

There are 312 beds in Children's Memorial Hospital - Northwestern University.

During the past decade, Children's Memorial Hospital - Northwestern University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Memorial Hospital - Northwestern University" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Aegerion Pharmaceuticals, Inc." with 1 trials sponsored, "Kari Christine Nadeau" with 1 trials sponsored, "Target PharmaSolutions, Inc." with 1 trials sponsored and "University of California, Los Angeles" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Memorial Hospital - Northwestern University" #1 collaborator was "Ann & Robert H Lurie Children's Hospital of Chicago" with 1 trials as a collaborator, "BioMarin Pharmaceutical" with 1 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator, "Children's Hospital Los Angeles" with 1 trials as a collaborator and "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Children's Memorial Hospital - Northwestern University" are "Cystic Fibrosis" (2 trials), "Alopecia Areata" (1 trials), "Atopic Dermatitis" (1 trials), "Chronic Spontaneous Urticaria" (1 trials) and "Food Allergy" (1 trials). Many other conditions were trialed in "Children's Memorial Hospital - Northwestern University" in a lesser frequency.

Most popular intervention types in "Children's Memorial Hospital - Northwestern University" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "AZLI 75 mg three times a day (TID)" (1 trials), "AZLI 75 mg two times a day (BID)/three times a day (TID)" (1 trials), "Food Flour Buildup" (1 trials), "Kuvan" (1 trials) and "Omalizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Children's Memorial Hospital - Northwestern University" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Children's Memorial Hospital - Northwestern University". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Children's Memorial Hospital - Northwestern University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Memorial Hospital - Northwestern University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".